Related content

Sample Size Calculations for the Development of Biosimilar Products

By    

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1215-1224

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Assessment of Biosimilar Products

By Chow Shein-Chung  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 10-30

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Consistency Approach for Evaluation of Biosimilar Products

By Tsou Hsiao-Hui   Chang Wan-Jung   Hwang Wong-Shian   Lai Yi-Hsuan  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1054-1066

Taylor & Francis Ltd

Access to resources Recommend Favorite

Funding a Clinical Trial: The Perspective of a Medicines Funder

By Alsop Peter   Metcalfe Scott   Evans Jackie  

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 811-814

Adis International

Access to resources Recommend Favorite

Selective Reporting, Publication Bias and Clinical Trial Registry: An Industry Perspective

By Berlin Jesse A.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 5-6, 2005-01 ,pp. : 277-284

Adis International

Access to resources Recommend Favorite